David D. Email & Phone Number

Washington, District Of Columbia, United States

I provide strategic legislative and regulatory policy advice to the life sciences industry.

Washington DC-Baltimore Area

I focused on telling the innovation story for pharmaceuticals and other medical products, and I assessed US legislative proposals that could impact the development of Johnson and Johnson’s medical products.

Rockville, MD

I led Janssen's pharmaceutical regulatory policy work focused on the US FDA, assessed proposed legislation that could affect Janssen, and supported select policy work of Johnson and Johnson's medical device and consumer divisions

Silver Spring, MD

• I led Office of Policy and Planning (July 2011-September 2012) and Office of Policy, Planning, and Budget (September 2009-July 2011), responsible for:
• Development, review, and/or clearance of FDA policy, regulations, guidance documents, citizen petitions responses, reports to Congress, responses to reports by the General Accountability Office and the Office of.
• Formulation of agency budget proposals to the Department of Health and Human Services, the Office of Management and Budget, and the Congress
• Staffing FDA Commissioner at select oversight and appropriations hearings
• Representing FDA in meetings with Congressional staff, stakeholders, and the public
• Management and strategic use of office budget and hiring

Silver Spring, MD

• I advised FDA Commissioner and Acting FDA Commissioner on policy issues
• I oversaw FDA Office of Legislation; coordinated and led agency assistance to the House Energy and Commerce Committee on food safety legislation; led development and selection of supply chain safety proposals; reviewed.

Washington, DC

• Developed Senator Kennedy’s FDA-related legislative agenda Advised and staffed Senator Kennedy on all FDA-related issues and hearings Drafted and negotiated in Senate and in formal and informal conferences with the.
• Food and Drug Administration Amendments Act of 2007 (P.L. 110-85)
• Pandemic and All-Hazards Preparedness Act (P.L. 109-417) (Title IV, countermeasure development)
• Dietary Supplement and Nonprescription Drug Consumer Protection Act (P.L. 109-462)
• Project BioShield Act of 2004 (P.L. 108-276)
• Minor Use and Minor Species Animal Health Act of 2004 and Food Allergen Labeling and Consumer Protection Act of 2004 (P.L. 108-282)

Rockville, MD

• I counseled the agency on the regulation of medical devices, tobacco products, food labeling, and dietary supplements, including by reviewing regulations and guidance documents

Jd

M.A., Mathematics

Bachelor Of Arts - Ba, Mathematics